🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The purpose of this study is to assess duration of protection for GSK DTaP ...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02447978
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
Recombinant acellular pertussis vaccines containing genetically detoxified ...
Status
Completed
Location
Vaccine Trial Centre (VTC), Faculty of Tropical Medicine, Mahidol University
Start Date
2020-07-13
Trial ID
NCT07213089
Treatments Being Tested
This study will evaluate the safety and immune response of the Novartis Men...
Status
Completed
Location
Growing Up Pediatrics
Start Date
2007-03
Trial ID
NCT00474526
This phase IV trial tests whether a single dose of the human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Start Date
2022-03-01
Trial ID
NCT05237947
This study will determine whether participants who receive V419 (PR5I) at 2...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-23
Trial ID
NCT01480258
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
This phase IV trial investigates whether one dose of a human papillomavirus...
Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Start Date
2017-11-29
Trial ID
NCT03180034
This is a follow-up of Study A3L11 (NCT00404651). Immunogenicity * To des...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00654901